A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$47.71-0.87 (-1.79%)
NVS$55.66-0.58 (-1.03%)
SNY$35.51-0.33 (-0.92%)
GSK$46.01-0.59 (-1.27%)
Head and Neck Cancer Information Center
Folder Conference Coverage
 
People Current Topics
 
News Latest Head and Neck Cancer News

Advexin® Improves Survival in Head and Neck Cancer (7/31/2008)
The targeted agent Advexin® (p53 tumor suppressor therapy) improves survival compared with methotrexate among head and neck cancer patients with the p53 biomarkers.  These results were recently presented at the American Association for Cancer Research (AACR) Centennial Conference on Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine.

IMRT and Chemotherapy Effective for Stage III-IV Oropharyngeal Carcinoma (7/25/2008)
Researchers from the University of California at San Francisco have reported a 90% loco-regional progression-free survival in patients with Stage III-IV oropharyngeal carcinoma treated with intensity modulated radiation (IMRT) and chemotherapy without surgery. The details of this Phase II study appeared in the August 1, 2008 issue of Cancer.

Acupuncture Reduces Pain after Neck Dissection (6/6/2008)
According to the results of a study presented at the 2008 annual meeting of the American Society of Clinical Oncology, acupuncture is more effective than usual care in reducing pain and dysfunction following neck dissection for head and neck cancer.

Several Non-AIDS-Defining Cancers Increased in HIV-Positive Persons (5/23/2008)
Researchers from the Centers for Disease Control have reported that several types of cancer are increased in HIV-positive persons compared with the general population. The details of this study were published in the May 20, 2008 issue of the Annals of Internal Medicine.

Pulsed Angiolytic Laser Therapy Effective for Laryngeal Cancer (5/9/2008)
Researchers from Massachusetts General Hospital have reported promising results of treatment of early-stage laryngeal cancer with a new laser called the pulsed angiolytic KTP. The details of this Phase II study were presented at the 2008 meeting of the Broncho-Esophagological Association meeting in Orlando, Florida, on May 1. Details of this study are available on the Massachusetts General Web site, and a definitive report will be published in the July 2008 issue of the Annals of Otology, Rhinology and Laryngology.

More Head and Neck Cancer News »

Head and Neck Cancer Drug Pipeline

What's in the pipeline for Head and Neck Cancer.
Newsletters

Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.
 
Information by Cancer Type

 Supportive Care Centers

 Physician Resources




© 1998-2007 CancerConsultants.com  All Rights Reserved.